Cancer research is a solution that solves many impediments to a patient
receiving appropriate cancer care including treatment costs and lack of
options. Research trials provide more treatment options for patients, often
cover travel costs, and shift most of the cancer care costs to the trial
sponsor (pharmaceutical company). Unfortunately, today, only 3-5% of cancer
patients ever enroll on a clinical trial. The only way to develop new cancer
treatments is to enroll patients on research trials. The faster trials are
accrued, the faster a determination can be made by the FDA for a potential
cancer treatment. There is a limited number of cancer treatments approved
for each type of cancer. Yet there are hundreds to thousands of research
trials for each type of cancer that hold potential and hope for cancer
patients. There are many reasons why only 3-5% of cancer patients concern
participation in a clinical research trial, including lack of physicians who
participate in research trials, lack of patient knowledge that research
trials exist, and a number of myths & misconceptions regarding research that
often scares patients away.
Common Myths & Misconceptions of Cancer Research Trials